CD28 and non-small cell lung carcinoma: For example, the expression of CD28 in T cells was frequently used as a maker of differentiation degree, and expansion of CD28-CD4+ T cells in peripheral blood within the first cycle of therapy was considered an early sign of HPD in NSCLC treated with ICIs (37).